Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?

Moderna just posted an 11% surge with zero news behind it, while its longtime mRNA peer BioNTech can barely keep pace with the broader biotech sector. Something broke between these two names, and figuring out what it means for your position is more urgent than it looks.